PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
12-Jul-2023 Direct Biologics Announces Publication of Significant Survival Benefit with ExoFlo™ in its Phase 2 Randomized Controlled Clinical Trial in the Journal CHEST Businesswire
12-Jul-2023 Seagen to Report Second Quarter 2023 Financial Results on August 2, 2023 Businesswire
12-Jul-2023 With New $30M Series A Extension, Allonnia Takes Aim At Scaling Solutions to the World’s Toughest Environmental Challenges Businesswire
12-Jul-2023 Global Biologics Contract Development Market Report 2023: Sector is Expected to Reach $13.8 Billion by 2030 at a CAGR of 8.1% - ResearchAndMarkets.com Businesswire
12-Jul-2023 Surmodics to Report Third Quarter of Fiscal 2023 Financial Results on August 2 Businesswire
12-Jul-2023 Global Pharmaceutical Filtration Market 2023-2030: Rising Purity Demands Drive Sector Growth in End-User Applications - ResearchAndMarkets.com Businesswire
12-Jul-2023 AVROBIO to Explore Strategic Alternatives Businesswire
12-Jul-2023 bit.bio Launches Two New Human Cell Disease Models to Advance Discovery and Development of Treatments for Duchenne Muscular Dystrophy (DMD) Businesswire
12-Jul-2023 Glaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023 Businesswire
12-Jul-2023 Movius Appoints Lisa Davis to Board of Directors Businesswire
12-Jul-2023 BeiGene Announces FDA Acceptance of sNDA for Fifth BRUKINSA® Indication Businesswire
12-Jul-2023 Global Antibiotics Market Report 2023: Sector is Expected to Reach $68.04 Billion by 2030 at a CAGR of 4.26% - ResearchAndMarkets.com Businesswire
12-Jul-2023 Tenpoint Therapeutics Launches with $70 Million Series A Financing to Reverse Vision Loss Through Engineered Cell-Based Therapeutics and In Vivo Reprogramming Businesswire
12-Jul-2023 Ault Alliance Issues Letter to Stockholders Businesswire
12-Jul-2023 Immunis Releases Video Showcasing its Advanced Biotech Infrastructure Businesswire
12-Jul-2023 Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules Businesswire
12-Jul-2023 RWS Holdings plc Acquires Leading Legal and Regulatory Content Management Solution Provider Propylon Holdings Limited Businesswire
12-Jul-2023 AmplifyBio Completes Acquisition of Intellectual Property to Offer Non-Viral Gene Editing Services for Clients Newswire
12-Jul-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
12-Jul-2023 Ora, Inc. Partners with the North West London Clinical Trials Alliance to Accelerate Patient Access to Cutting-Edge Ophthalmology Treatments Businesswire